Healthcare buyers expect discretion. Most of our work happens under NDA, on cap-table-sensitive procurement cycles, or inside hospital systems that don't enjoy being a marketing case study. The three below are sanitized, anonymized, and accurate. References to specific founders, executives, and revenue numbers are available on request after the diagnostic call.
A care-in-the-home platform with strong product traction and a reference customer was stuck at one paying integrated delivery network after eighteen months of selling. The discovery framework was built for value-based-care plans; the buyer was the IDN's discharge-planning leadership. The motion didn't fit the buyer.
By the time we engaged, four AEs had cycled through five-month tenures with the founder taking over each pursuit at month three. Pipeline coverage looked healthy on the dashboard but every late-stage deal was the same kind of stuck.
Adam led the engagement with Mike on RevOps. Twelve weeks: rebuild discovery around discharge-planning workflow (not VBC contracting), retrain the four AEs on clinical-stakeholder mapping, and personally lead the first three IDN pursuits while the team observed. We sat in twenty-six pipeline reviews and rode forty-one demos.
Week six was the first signed pilot. Week nine and week eleven were the next two. The motion was hardened by the time we left at week sixteen — the next IDN closed the week after our handoff, with the AE running it solo.
A pre-revenue digital-health company with a clinically validated product and a payer-facing wedge — but zero direct payer relationships, no procurement playbook, and a founder who had run two consumer companies and was learning the buyer in real time. Six weeks until the next board meeting.
Six-week sprint covering ICP refinement, account map across the top fifteen national plans, executive intros into each (Adam's network), pricing teardown against three comparable wedges, and a procurement-ready value story.
By week six the founder had fourteen plan POCs, two of which converted to paid pilots within the next quarter. The board meeting went well.
An AI-native healthtech company where the founder was on every demo, every discovery call, and every procurement review. Pipeline was strong but throughput was capped at one founder's calendar. Two new AE hires had been considered for nine months; neither happened because the founder didn't trust the deal pattern was coachable.
Mike led the engagement with Adam on the buyer-side coaching. Documented the founder's deal pattern across twelve recorded calls, converted it into an AE scorecard and ramp plan, ran the hiring loop for two AEs, and stayed through ramp.
The founder was off late-stage demos within ninety days. Both AEs hit quota in their second full quarter. The founder is now spending two-thirds of their time back in product.
If you're considering Bayshore for a specific situation — a payer pursuit, an IDN procurement cycle, an AI-native GTM rebuild — we'll match you to the closest analog from past work and put you on the phone with a reference. Ask on the diagnostic call.
Tell us the shape of the problem on the diagnostic call. If we've solved a version of it, we'll connect you with a founder who lived it.
Where the practice is anchored. We travel for kickoffs, key pursuits, and exec-sponsor meetings — wherever the deal is.
The first call ends with a clear yes or no on fit. We'll send references and a sample deliverable beforehand if it helps.